Search
Home
Products
Enterolactone
Enterolactone WeChat WhatsApp
Product Name Enterolactone
Price: Inquiry
Catalog No.: CN02650
CAS No.: 78473-71-9
Molecular Formula: C18H18O4
Molecular Weight: 298.3 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Powder
Source: The seeds of Linum usitatissimum L.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
SMILES:
Contact us
First Name:
Last Name:
E-mail:
Question:
Description Enterolactone is a bioactive phenolic metabolite known as a mammalian lignan derived from dietary lignans. Enterolactone has estrogenic properties and anti-breast cancer activity[1]. Enterolactone is a radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis[2].
In Vitro Enterolactone (25-75 μM; 48 hours) arrests the growth of MDA-MB-231 breast cancer cells in the ‘S’ phase[1] Enterolactone (25-75 μM; 15 hours) triggers apoptosis in MDA-MB-231 breast cancer cells via caspase-3 activation[1]. Enterolactone inhibits TGF-β-induced migration of MDA-MB-231 breast cancer cells. Enterolactone inhibits TGF-β-induced invasion of MDA-MB-231 breast cancer cells through ECM. Enterolactone inhibits the TGF-β-induced EMT program in MDA-MB-231 breast cancer cells. Enterolactone reduces the formation of actin stress fibers by inhibiting the expression of CD44 and MAPK-p38. Enterolactone inhibits the ERK/NF-κB/Snail signaling pathway to revert TGF-β-induced EMT in MDA-MB-231 cells[1]. Cell Viability Assay[1] Cell Line: MDA-MB-231 cells Concentration: 25, 50, 75 μM Incubation Time: 48 hours Result: There was a non-significant increase (~24%) in the S phase population following treatment with 25 μM EL, whereas there were significant increases (~34% and ~39%) following treatment with 50 and 75 μM EL, respectively.
Density1.3±0.1 g/cm3
Boiling Point561.4±25.0 °C at 760 mmHg
Flash Point209.0±16.7 °C
Exact Mass298.120514
PSA66.76000
LogP2.29
Vapour Pressure0.0±1.6 mmHg at 25°C
Storage condition2-8°C